HSBC Holdings’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$190K Hold
49,449
﹤0.01% 2628
2025
Q4
$97.9K Sell
49,449
-149
-0.3% -$244 ﹤0.01% 2793
2025
Q3
$40.1K Hold
49,598
﹤0.01% 2656
2025
Q2
$36.3K Sell
49,598
-5,549
-10% -$4.17K ﹤0.01% 2955
2025
Q1
$46.4K Sell
55,147
-37
-0.1% -$55 ﹤0.01% 2910
2024
Q4
$92.2K Buy
55,184
+35,650
+183% +$85.3K ﹤0.01% 2903
2024
Q3
$56.6K Buy
19,534
+2,066
+12% +$5.35K ﹤0.01% 2871
2024
Q2
$40.5K Sell
17,468
-8,066
-32% -$21.1K ﹤0.01% 2834
2024
Q1
$75.1K Buy
25,534
+7,070
+38% +$20.1K ﹤0.01% 2888
2023
Q4
$60.2K Hold
18,464
﹤0.01% 2637
2023
Q3
$57.8K Hold
18,464
﹤0.01% 2614
2023
Q2
$70K Hold
18,464
﹤0.01% 2475
2023
Q1
$50.8K Hold
18,464
﹤0.01% 2564
2022
Q4
$32.3K Hold
18,464
﹤0.01% 2992
2022
Q3
$41K Hold
18,464
﹤0.01% 2836
2022
Q2
$48K Hold
18,464
﹤0.01% 3143
2022
Q1
$80K Hold
18,464
﹤0.01% 3157
2021
Q4
$96K Buy
+18,464
New +$98.8K ﹤0.01% 3145

Other funds holding NAUT

HSBC Holdings's NAUT Position: Q1 2026 in Review

HSBC Holdings held its Nautilus Biotechnolgy (NAUT) position steady in Q1 2026 at 49,449 shares worth $190K. The position accounts for ﹤0.01% of the portfolio, ranked #2628.

HSBC Holdings first reported a position in NAUT in Q4 2021 and has held it in 18 quarters since. 81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.

  • HSBC Holdings held 49,449 shares of Nautilus Biotechnolgy worth $190K as of Q1 2026.
  • HSBC Holdings left its Nautilus Biotechnolgy share count unchanged in Q1 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2628 holding.
  • HSBC Holdings first reported a position in Nautilus Biotechnolgy in Q4 2021 and has held it in 18 quarters since.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.